Delivery Order SPE2DE24DA010-SPE2D625F9X8X
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,500 fixed-price delivery order with economic price adjustment for leadless accessories by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract, with an ultimate completion date of July 31, 2025, represents a child award under Abbott's broader federal cardiovascular medical device portfolio. No set-aside designation was applied to this award, indicating full and open competition....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a $2,000 delivery order for leadless accessories by the Medical Supply Chain division of the Department of Defense on September 12, 2025, with an ultimate completion date of September 17, 2025. The contract is a fixed-price delivery order with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance will take place in Santa Clara,...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $14,850 on November 14, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 19, 2025, and will be performed in Santa Clara, California. The award represents a child contract under Abbott Laboratories Inc.'s broader federal contracting portfolio and was made...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order valued at $5,695.00 by the Defense Logistics Agency's Medical Supply Chain division. The contract, issued on May 20, 2025, with an ultimate completion date of June 9, 2025, represents a child contract under Abbott Laboratories Inc.'s parent entity and will be performed in Santa Clara, California. This delivery order was awarded without a set-aside designation, indicating full and...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on November 14, 2025, with an ultimate completion date of November 19, 2025. The delivery order, which carries no set-aside designation, will be performed in Santa Clara, California. This award represents a task order issued under Abbott's existing $117.1 million Indefinite Delivery Contract with the Defense...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order valued at $24,350 by the Defense Logistics Agency's Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 5, 2025. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting Abbott's competitive positioning among qualified federal contractors. Performance will take place in...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award (Contract No. 4570109351) valued at $6,874.00 from the Defense Logistics Agency's Medical Supply Chain on November 25, 2025. The contract utilizes a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by December 1, 2025. The award carries no set-aside designation and represents a discrete delivery order issued under Abbott's established...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc.'s Abbott Vascular division was awarded a delivery order valued at $5,695 on December 11, 2025, under a Defense Logistics Agency Medical Supply Chain contract. This fixed-price delivery order with economic price adjustment authority is scheduled for completion by January 6, 2026, and will be performed in Santa Clara, California. The award utilized full and open competition with no set-aside designation. This delivery order represents a task order draw against Abbott's...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, received a delivery order award valued at $1,120.00 from the Defense Logistics Agency's Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 15, 2025. The contract utilizes fixed-price pricing with economic price adjustment and represents a child contract under Abbott Laboratories Inc.'s parent entity. No small business set-aside was applied to this award, indicating full and open competition....
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F9X8XDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for leadless accessories with a ceiling value of $1,500. The contract, awarded on May 30, 2025, utilizes fixed-price pricing with economic price adjustment provisions and has an ultimate completion date of June 4, 2025. This delivery order represents a child contract with no set-aside designation, indicating full and open competition. The work will be performed in Santa Clara, California. This award reflects Abbott Vascular's established role as a critical supplier of cardiovascular medical technologies to federal defense healthcare systems. The company maintains a substantial indefinite delivery vehicle with the DLA valued at over $117 million for comprehensive procedural packages, cardiovascular devices, instrumentation, and accessories. The leadless accessories delivery order falls within Abbott's broader portfolio of advanced cardiac technologies provided to federal agencies, supporting the delivery of sophisticated medical devices and related services to Department of Defense healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/30/25 |